Improving Diagnosis of Some of the Most Common Genetic Disorders in Children

  • July 8, 2021

    69 News 

  • “There are currently around 7,000 identified genetic disorders or rare diseases. Some of these affect only a handful of individuals globally, others can affect thousands. Genetic disorders present with a variety of characteristic facial features, and symptoms, and can be caused by a genetic mutation or chromosomal anomaly. FDNA enables families to connect with their global network of genetic experts, and their own advanced genetic analysis technology, in order to ensure a more accurate and timely diagnosis.”

 

The article describes how FDNA is expediting the diagnosis of common genetic disorders in children. Using advanced AI technology, their Face2Gene tool analyzes facial features to identify genetic anomalies. FDNA makes diagnostic consultations more accessible, particularly for underserved or remote areas. The platform allows photos to be uploaded for analysis, providing quick and accurate diagnostic suggestions. This approach improves early diagnosis and personalized treatment plans. FDNA’s innovative solutions significantly advance the identification and management of genetic disorders in children, leading to better patient outcomes.

 

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading